Corticotropin releasing factor to prevent fluid leakage from blood vessels in the lung: Began a second Phase I/II trial for chronic asthma patients treated at c

Neurobiological Technologies Inc. (NTII), Richmond, Calif. Product: Corticotropin releasing factor to prevent fluid leakage from blood vessels in the lung Indication: Chronic asthma Status: Began a se...